Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Nov 27, 2018 at 12:00 PM EST

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb shares dipped on Tuesday after the company reported results from its late-stage lung cancer study.

Chris Lange | Nov 27, 2018 at 10:25 AM EST

Why Wedbush Is Staying Positive on Zafgen

Despite this crushing loss where we saw shares down about 41% on Monday, one analyst is still positive on the…

Chris Lange | Nov 26, 2018 at 10:25 AM EST

Why Zafgen Shares Got Stomped

Zafgen shares were absolutely crushed on Monday after the company announced an update from the FDA.

Chris Lange | Nov 19, 2018 at 1:42 PM EST

Why One Top Drug Stock Could Have Nearly 30% Upside

Mallinckrodt has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach…

Chris Lange | Nov 17, 2018 at 8:35 AM EST

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Here 24/7 Wall St. takes a look at a recent report by Canaccord Genuity regarding to biotech and pharmaceutical companies…

Chris Lange | Nov 15, 2018 at 12:05 PM EST

Seattle Genetics Dips Despite FDA Win

Seattle Genetics shares dipped on Monday following an update from the FDA on Adcetris for certain lymphomas.

Chris Lange | Nov 15, 2018 at 9:15 AM EST

Why Arena Pharma Is Winning Big With Its New Collaboration

Arena Pharmaceuticals shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics.

Chris Lange | Nov 14, 2018 at 9:55 AM EST

Synthorx Gears Up for IPO

Biopharmaceutical company Synthorx has filed with the SEC regarding its initial public offering.

Chris Lange | Nov 12, 2018 at 8:50 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Nov 9, 2018 at 7:05 AM EST

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all…

Jon C. Ogg | Nov 8, 2018 at 12:45 PM EST

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to…

Chris Lange | Nov 6, 2018 at 11:50 AM EST

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination…

Jon C. Ogg | Nov 6, 2018 at 11:40 AM EST

4 States Voting on Marijuana Legalization Efforts This Tuesday

Four states have marijuana legalization efforts of sorts up for grabs on Tuesday, November 6, 2018. Here is some basic…

Chris Lange | Nov 6, 2018 at 10:20 AM EST

Eli Lilly Dips Despite Solid Q3 Results

Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Nov 6, 2018 at 9:40 AM EST

Why Regulus Therapeutics Is Booming

Regulus Therapeutics shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and…

1 … 113 114 115 116 117 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Why Wedbush Is Staying Positive on Zafgen

Why Zafgen Shares Got Stomped

Why One Top Drug Stock Could Have Nearly 30% Upside

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Seattle Genetics Dips Despite FDA Win

Why Arena Pharma Is Winning Big With Its New Collaboration

Synthorx Gears Up for IPO

Short Sellers Raise the Stakes in Major Biotechs

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

4 States Voting on Marijuana Legalization Efforts This Tuesday

Eli Lilly Dips Despite Solid Q3 Results

Why Regulus Therapeutics Is Booming

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.

Qualcomm’s Path to $208 Runs Through Record Automotive Growth

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Health and Healthcare Articles

All Health and Healthcare Articles

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Why Wedbush Is Staying Positive on Zafgen

Why Zafgen Shares Got Stomped

Why One Top Drug Stock Could Have Nearly 30% Upside

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Seattle Genetics Dips Despite FDA Win

Why Arena Pharma Is Winning Big With Its New Collaboration

Synthorx Gears Up for IPO

Short Sellers Raise the Stakes in Major Biotechs

5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration

4 States Voting on Marijuana Legalization Efforts This Tuesday

Eli Lilly Dips Despite Solid Q3 Results

Why Regulus Therapeutics Is Booming

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

Featured Reads

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.